» Articles » PMID: 35359567

The 14-3-3 Protein Family and Schizophrenia

Overview
Specialty Molecular Biology
Date 2022 Apr 1
PMID 35359567
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia is a debilitating mental disorder that affects approximately 1% of the world population, yet the disorder is not very well understood. The genetics of schizophrenia is very heterogenous, making it hard to pinpoint specific alterations that may cause the disorder. However, there is growing evidence from human studies suggesting a link between alterations in the 14-3-3 family and schizophrenia. The 14-3-3 proteins are abundantly expressed in the brain and are involved in many important cellular processes. Knockout of 14-3-3 proteins in mice has been shown to cause molecular, structural, and behavioral alterations associated with schizophrenia. Thus, 14-3-3 animal models allow for further exploration of the relationship between 14-3-3 and schizophrenia as well as the study of schizophrenia pathology. This review considers evidence from both human and animal model studies that implicate the 14-3-3 family in schizophrenia. In addition, possible mechanisms by which alterations in 14-3-3 proteins may contribute to schizophrenia-like phenotypes such as dopaminergic, glutamatergic, and cytoskeletal dysregulations are discussed.

Citing Articles

Fragment-Based Interrogation of the 14-3-3/TAZ Protein-Protein Interaction.

Andlovic B, Valenti D, Centorrino F, Picarazzi F, Hristeva S, Hiltmann M Biochemistry. 2024; 63(17):2196-2206.

PMID: 39172504 PMC: 11375770. DOI: 10.1021/acs.biochem.4c00248.


Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression.

Zhao Y, Chen Y, Guo C, Li P, Cheng Z, Zheng L Theranostics. 2024; 14(9):3653-3673.

PMID: 38948066 PMC: 11209716. DOI: 10.7150/thno.92676.


Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery.

Kongsamut S, Eishingdrelo H Drug Discov Today. 2023; 28(8):103641.

PMID: 37236523 PMC: 10524340. DOI: 10.1016/j.drudis.2023.103641.


Exploring the Binding Mechanism of a Supramolecular Tweezer CLR01 to 14-3-3σ Protein Well-Tempered Metadynamics.

Zhou X, Shi M, Wang X, Xu D Front Chem. 2022; 10:921695.

PMID: 35646830 PMC: 9133541. DOI: 10.3389/fchem.2022.921695.


Rho-Rho-Kinase Regulates Ras-ERK Signaling Through SynGAP1 for Dendritic Spine Morphology.

Wu M, Funahashi Y, Takano T, Hossen E, Ahammad R, Tsuboi D Neurochem Res. 2022; 47(9):2757-2772.

PMID: 35624196 DOI: 10.1007/s11064-022-03623-y.

References
1.
Vega-Quiroga I, Yarur H, Gysling K . Lateral septum stimulation disinhibits dopaminergic neurons in the antero-ventral region of the ventral tegmental area: Role of GABA-A alpha 1 receptors. Neuropharmacology. 2017; 128:76-85. DOI: 10.1016/j.neuropharm.2017.09.034. View

2.
Fu H, Subramanian R, Masters S . 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol. 2000; 40:617-47. DOI: 10.1146/annurev.pharmtox.40.1.617. View

3.
Boston P, Jackson P, Thompson R . Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem. 1982; 38(5):1475-82. DOI: 10.1111/j.1471-4159.1982.tb07928.x. View

4.
Figgie Jr M, Appleby B . Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease. Viruses. 2021; 13(5). PMC: 8146465. DOI: 10.3390/v13050789. View

5.
Graham K, Zhang J, Qiao H, Wu Y, Zhou Y . Region-specific inhibition of 14-3-3 proteins induces psychomotor behaviors in mice. NPJ Schizophr. 2019; 5(1):1. PMC: 6386769. DOI: 10.1038/s41537-018-0069-1. View